Cultivates and sells cannabis products for medical and recreational use, focusing on innovative cannabis strains and formulations.
Organigram Holdings Inc., headquartered in Toronto, Canada, operates through its subsidiaries in the cannabis industry, focusing on the production and distribution of cannabis and cannabis-derived products. Established in 2010, the company serves both medical and adult-use recreational markets in Canada. For medical patients and veterans, Organigram offers a range of products such as cannabis flowers, oils, and vaporizers under various brands. In the adult-use segment, it markets products under well-known labels like SHRED, Edison Cannabis Co., and Monjour, catering to diverse consumer preferences.
In addition to its retail offerings, Organigram Holdings engages in wholesale activities, supplying cannabis plant cuttings, dried flowers, pre-rolls, and derivative-based products to retailers and wholesalers across Canada. The company's strategic approach includes leveraging online and telephone channels to reach a broad customer base efficiently. Organigram is recognized for its commitment to quality and innovation in cannabis cultivation and product development, contributing to its strong market presence and industry reputation.
With a focus on sustainability and regulatory compliance, Organigram Holdings Inc. emphasizes responsible cannabis production practices. The company's expansion efforts and strategic partnerships underscore its proactive stance in navigating the evolving cannabis market landscape. As it continues to grow, Organigram remains dedicated to meeting the diverse needs of its customers while driving forward advancements in the cannabis industry.